Cataract Surgery Abroad 2026: China vs Turkey vs India vs Korea

The four major cataract destinations all undercut Western private-pay pricing by a wide margin: India from about $600 per eye, China $300–1,200, Turkey $1,000–2,000 and South Korea $2,000–3,000 for a monofocal package (researched July 2026), against $3,500–5,000 US private-pay. But the headline number is the least interesting difference. This guide compares what the price tables don't show — surgical volume, lens availability, English access, and what happens if your work-up finds more than a cataract — and is honest about when each destination is the right answer.

Price by destination and lens class (researched July 2026)

Ranges are standard private-pay figures researched July 2026 from published clinic and facilitator pricing in each market, with China's figures drawn from our partner-hospital fee schedules — see what a trifocal or EDOF IOL costs in China, per eye for the per-lens breakdown. Two structural notes. First, the premium-lens gap is narrower than the monofocal gap: an imported Zeiss or Alcon trifocal costs roughly the same wholesale everywhere, so the cheaper the surgery around it, the more the lens dominates the bill. Second, Turkey prices are commonly quoted as flight-hotel-surgery packages, which blurs per-eye comparison — always ask for the medical figure alone, per eye, with the exact lens model in writing, whatever the country.

What the price table doesn't show

Surgical volume

Cataract surgery rewards repetition, and the volume rankings are not close. China performs more cataract operations than any other country — its national case volume runs into the millions per year, and flagship centers such as Zhongshan Ophthalmic in Guangzhou run some of the highest-volume cataract services in the world. India's big chains (Aravind, LV Prasad, private networks) operate at comparable intensity and pioneered high-throughput cataract care. Turkey and Korea run high standards at far lower volumes, concentrated in Istanbul and Seoul respectively. Volume isn't everything — but for a per-case operation like phaco, a surgeon's thousands of prior cases are the single most reassuring number you can ask about.

Lens availability

All four destinations implant the imported premium brands (Zeiss, Alcon, Johnson & Johnson). The difference is at the bottom of the range: China and India both have credible domestic IOL tiers that bring a monofocal package down substantially without changing the surgical technique — an option that simply doesn't exist in Turkey or Korea, where nearly all lenses are imported. If your goal is a safe, predictable monofocal outcome at minimum cost, that domestic tier is where the India/China price advantage comes from; if you want a specific imported trifocal model, ask every destination for that exact model's package price and the playing field flattens considerably.

If your eye has more than a cataract

This is the most under-discussed differentiator. A proper cataract work-up sometimes finds co-existing disease — glaucoma, macular degeneration, diabetic retinopathy. At a dedicated cataract clinic, that means a referral and often the end of your trip. At China's academic eye centers, the glaucoma and retina subspecialty departments are in the same building: a MIGS stent can be combined with your cataract surgery in one session, and a retinal finding gets a same-campus specialist opinion rather than a "see someone at home" letter. India's top institutions offer similar depth; Turkey's and Korea's cataract providers are more often standalone refractive-and-cataract clinics. If you're over 70, diabetic, or already on eye drops for pressure, weight this factor heavily — our glaucoma & retina cost guide covers what combined care looks like.

Language, records and aftercare

Turkey's medical-tourism industry is the most packaged — English-speaking coordinators are the default and European patients are the core market. Korea's international clinics are polished and expensive. China and India both deliver English care through international patient departments at major hospitals rather than industry-wide; in China that means routing your case through the right channel matters, which is exactly what a concierge (or our for-foreigners guide) is for. In all four countries the non-negotiable is the same: an English operative note stating the exact IOL model and power implanted, plus biometry and post-op findings, so your home optometrist can take over. A provider in any country that hesitates on that record set is the wrong provider.

Getting there and trip length

The interval between the eyes is worth understanding before you compare itineraries — see both eyes on one trip for what decides it and what a second trip adds to any of these totals.

Every destination can do both eyes in one trip if the surgeon is satisfied with the first eye's review — the interval is always a clinical call. Whichever country you choose, book flexible return travel; our flying after eye surgery guide explains the post-op flight-timing rules by procedure.

What happens after you fly home — the comparison almost nobody runs

Every table above compares the operation. The operation is the part that is over in twenty minutes and is, at a high-volume centre in any of these four countries, the least uncertain thing about the whole plan. What separates a cross-border cataract case from a local one is the tail: things that can happen weeks to years afterwards, at home, where the surgeon who operated on you cannot reach them. They belong in a destination comparison because price tables silently assume they do not exist — and because two of the three turn out not to depend on the destination at all, which is worth knowing before it changes your decision.

The near-certain one: the capsule clouds, and no destination can fix it for you

During cataract surgery the lens capsule is deliberately left in place to hold the new implant. In a proportion of eyes it gradually clouds — posterior capsule opacification, sometimes called a “secondary cataract”, though it is neither a cataract nor a complication. Vision goes hazy again, often a year or more later, and patients who were operated on abroad frequently read it as proof that the cheap surgery failed. It is not. Pooled figures from older published series put the incidence near 12% at one year and 28% at five; modern square-edged implant designs have reduced that materially, and the real rate varies with lens design, age and the individual eye.

The fix is a YAG laser capsulotomy — a few minutes at a slit lamp, no incision, no recovery period. The point for a destination comparison is that it happens at home and it is priced at home. Published US private-pay figures run roughly $400–900 per eye (researched September 2026), and it is routinely covered by Medicare and by most insurance; UK private rates are broadly comparable, with NHS routes for those who qualify. That figure is the same whichever country you flew to — which is precisely why it should not move your destination choice, and precisely why it belongs in your budget rather than in your comparison. Any provider whose package claims to prevent it is describing something that is not in their control.

What does make a difference here is not the country: it is the implant chosen and whether an ophthalmologist at home can see what was put in your eye. Our cataract cost guide sets out the lens classes; the record set below is what makes the second possible.

The uncommon one that really is destination-sensitive: a refractive surprise

The implant's power is chosen before surgery from biometry — measurements of the eye's length and corneal curvature — run through a calculation formula. Modern formulas are good, but a share of eyes still land away from the intended target, and the spread is wider in very long or very short eyes, in eyes with significant astigmatism, and markedly wider if you have had LASIK, PRK or RK, because the cornea no longer behaves the way standard formulas assume. The result is not a failure; it is a spectacle prescription you were not expecting.

The remedies are glasses or contact lenses, a corneal laser touch-up, or — rarely — exchanging the implant. The last two need a surgeon and an operating theatre, and this is where the destinations genuinely differ, though not in the way most people assume: returning is impractical from all four. What varies is whether the clinic will commit to a position in writing before you pay, and whether the records it sends home are good enough for a surgeon in your own country to act on without repeating the entire work-up. Ask for the biometry device and the formula by name, your target refraction, and the clinic's stated position on a significant miss — in writing, before any deposit. A provider in any country that will not answer that has answered it.

The rare one: what recourse actually looks like from six thousand miles away

Serious complications after modern cataract surgery are uncommon wherever it is performed. The honest position, which destination round-ups tend to skip, is that if one does occur your practical remedy is clinical rather than legal, in every one of these countries — and that this is an argument for how you verify a provider beforehand, not an argument against travelling.

The consistent line across that table is that verification before you travel substitutes for remedy afterwards — everywhere, including at home, where litigation is also a poor consolation for a bad outcome. What that means in practice is checking the operating surgeon's name, their licence, their cataract volume and the institution's tier before you pay, rather than relying on a coordinator's assurances. Our hospital guide shows how the Chinese tier system reads from outside, and the safety guide lists the verification steps in full.

The tail, in one table

The reading we would draw from that column: three of the four are destination-neutral, so the tail is a weaker argument against operating abroad than it first appears — and a much stronger argument for the record set, the return-flight slack and the written policy than for paying a premium to a particular country. Our aftercare-at-home guide covers the first six weeks in detail, and the insurance and records guide covers what your insurer will want to see.

When each destination makes sense

• Choose India if minimum cost is the priority, you're comfortable navigating a large private-hospital system (or have family in-country), and your case is routine.
• Choose Turkey if you're in Europe, want a short flight and a packaged trip, and you're getting a standard monofocal or well-specified trifocal at a high-volume Istanbul clinic.
• Choose Korea if service polish and Seoul logistics justify a premium over the other three — the medicine is excellent, but on international-patient terms you're paying closer to Western rates. The lower Korean figures you will find elsewhere are domestic-facing prices for residents whose National Health Insurance is paying part of the bill; our China vs Korea comparison puts both columns in one table and explains which one applies to you.
• Choose China if you want the deepest institutional bench for the money: top-five global case volume, the full imported-lens range plus a domestic budget tier, and academic centers that can absorb a surprise finding (glaucoma, retina) without ending your trip. Our hospital guide shows which institution fits which condition.

This page compares one procedure. If your eye problem is something other than a cataract — corneal disease, orbital or eyelid surgery, glaucoma surgery, complex retinal work, or a condition treated with expensive drugs rather than theatre time — the destination logic changes, and in several of those cases it points somewhere other than China. Our destination guide organised by diagnosis works through it, and the companion insurance, HSA/FSA and records guide covers what any of these countries will and will not be reimbursed for.

Frequently asked questions